A rat knock-in model carrying the FAD/EOAD Swedish mutation of APP (Apps rats) recapitulated the shift toward amyloidogenic processing of APP seen in AD patients with the same mutation, which was associated with increased release probability of synaptic vesicles in glutamatergic hippocampal neurons (Tambini et al., 2019). The gene discussed is APP; the disease is Alzheimer disease.